Logo En IconLogo Mark IconIcelandic Intellectual Property Office
Plus Black IconMortgagePlus Black IconLicense

SPC456

Pirtóbrútíníb eða lyfjafræðilega viðunandi sölt þar af

  • Status:
    Veitt
  • Application date:
    1.3.2024
  • Application published:
    15.4.2024
  • Grant published:
    15.10.2025
  • Max expiry date:
    30.10.2038
  • Medicine name:
    Jaypirca
  • Medicine for children:
    No

Timeline

Today
1.3.2024Application
15.4.2024Publication
15.10.2025Registration
30.10.2038Expires

Marketing license

  • IS authorization number:
    EU/1/23/1738
  • Date:
    28.11.2023
  • Foreign authorization number:
    EU/1/23/1738
  • Date:
    30.10.2023

Owner

  • Name:
    Loxo Oncology, Inc.
  • Address:
    Lilly Corporate Centre Indianapolis, Indiana 46285 US

Agent

  • Name:
    Árnason Faktor ehf.
  • Address:
    Guðríðarstíg 2-4, 113 Reykjavík

Patent

Deadlines

TypeDeadline until

Type: Frestur til að fara yfir drög að vottorði

Deadline until: 08.10.2025

Upload documents